Breaking News Instant updates and real-time market news.

RHHBY

Roche

$0.00

(0.00%)

11:45
09/20/19
09/20
11:45
09/20/19
11:45

Roche reports FDA approves cobas Babesia test

Roche announced that it has received approval from the U.S. Food and Drug Administration for the cobas Babesia test for use on the cobas 6800/8800 Systems for individual blood donation testing. "This is Roche's first commercially available whole blood test to screen donations and follows May 2019 FDA-updated industry guidance recommending screening and testing for Babesia, to reduce the risk of transmitting the parasite through transfusions," the company stated.

  • 04

    Nov

RHHBY Roche
$0.00

(0.00%)

07/23/19
BTIG
07/23/19
INITIATION
Target $46
BTIG
Buy
Adaptive Biotechnologies initiated with a Buy at BTIG
BTIG analyst Amanda Murphy initiated Adaptive Biotechnologies (ADPT) with a Buy rating and a price target of $46, saying the company's "clinical immunomics database" represents its "differentiating asset" and offers "incredible value" to biopharma companies. The analyst further cites Adaptive Biotechnologies' partnership with Roche (RHHBY) that should allow it to develop new diagnostics for early detection of diseases where antigens are unknown and also its "strategic" deal with Microsoft (MSFT), whose machine learning capabilities support its immune medicine platform.
07/23/19
JPMS
07/23/19
NO CHANGE
JPMS
Neutral
Competition questions for Biogen, Ions' Spinraza not dissipating soon, says JPMorgan
Following Biogen's (BIIB) quarterly results, JPMorgan analyst Jessica Fye notes that while there seems to be limited second quarter impact to the company's and partner Ions Pharmaceuticals' (IONS) Spinraza from Novartis' (NVS) Zolgensma international revenues were down quarter over quarter for a variety of reasons despite double-digit patient growth. Overall, the analyst maintains her view that Roche (RHHBY) and PTC Therapeutics' (PTCT) Risdiplam represents a key potential competitive threat to Spinraza given the convenience of oral dosing and with filing for Risdiplam anticipated in the second half of 2019, in addition to Zolgensma's launch, Fye does not see questions related to competition for Spinraza dissipating anytime soon. The analyst reiterates a Neutral rating on Ions Pharmaceuticals' shares.
07/26/19
UBSW
07/26/19
UPGRADE
UBSW
Buy
Roche upgraded to Buy from Neutral at UBS
UBS analyst Michael Leuchten upgraded Roche to Buy from Neutral and raised his price target for the shares to CHF 300 from CHF 270. The company's legacy portfolio, built around Herceptin and Rituxan, is showing greater resilience while its "credible" neuroscience pipeline is taking shape, Leuchten tells investors in a research note. As such, he now sees Roche's business model as less challenged.
09/13/19
DBAB
09/13/19
NO CHANGE
DBAB
Hold
Novartis' ofatumumab to be 'strong' competitor to Roche drug, says Deutsche Bank
Deutsche Bank analyst Richard Parkes tells investors in a research note after attending the ECTRIMS conference in Stockholm that data from Novartis' (NVS) ASCLEPIOS trials suggests ofatumumab will be a "strong" competitor for Roche's (RHHBY) Ocrevus in relapsing/remitting multiple sclerosis. Parkes says he expects physicians to view the drugs as having broadly comparable and highly compelling efficacy, with ofatumumab's at-home dosing an attractive option for some patients, suggesting meaningful upside potential to his current 2024E ofatumumab sales of $1.1B and possible risks to his forecasts for Roche's Ocrevus. According to physician feedback, Parkes says the drugs are likely to share a rapidly growing market. Parkes maintains a Hold rating and 90 CHF price target on Novartis shares.

TODAY'S FREE FLY STORIES

09:46
10/22/19
10/22
09:46
10/22/19
09:46
Hot Stocks
Breaking Hot Stocks news story  »

Tiberius Acquisition…

09:45
10/22/19
10/22
09:45
10/22/19
09:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

09:45
10/22/19
10/22
09:45
10/22/19
09:45
General news
Existing Home Sales to be reported at 10:00 »

September Existing Home…

09:45
10/22/19
10/22
09:45
10/22/19
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

October Richmond Fed…

SYMC

Symantec

$23.08

(0.00%)

09:42
10/22/19
10/22
09:42
10/22/19
09:42
Conference/Events
House Committee on Homeland Security to hold a hearing »

The Cybersecurity,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

HCA

HCA Healthcare

$123.62

(0.00%)

, HOG

Harley-Davidson

$37.14

(0.00%)

09:40
10/22/19
10/22
09:40
10/22/19
09:40
Options
Unusually active option classes on open October 22nd »

Unusual total active…

HCA

HCA Healthcare

$123.62

(0.00%)

HOG

Harley-Davidson

$37.14

(0.00%)

BIIB

Biogen

$223.57

(0.00%)

WPM

Wheaton Precious Metals

$26.00

(0.00%)

CIEN

Ciena

$38.40

(0.00%)

MCD

McDonald's

$209.85

(0.00%)

UPS

UPS

$118.56

(0.00%)

MRK

Merck

$84.54

(0.00%)

PG

Procter & Gamble

$119.04

(0.00%)

NVDA

Nvidia

$196.16

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 06

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 18

    Nov

  • 20

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HHC

Howard Hughes

$128.38

2.41 (1.91%)

09:39
10/22/19
10/22
09:39
10/22/19
09:39
Recommendations
Howard Hughes analyst commentary  »

Howard Hughes review…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

GRUB

GrubHub

$55.78

-0.02 (-0.04%)

09:37
10/22/19
10/22
09:37
10/22/19
09:37
Recommendations
GrubHub analyst commentary  »

Recent pullback in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

UPS

UPS

$118.56

1.23 (1.05%)

09:37
10/22/19
10/22
09:37
10/22/19
09:37
Hot Stocks
UPS says guidance may be affected if economy deteriorates »

Says: Expects EPS within…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

HOG

Harley-Davidson

$37.14

0.555 (1.52%)

09:37
10/22/19
10/22
09:37
10/22/19
09:37
Hot Stocks
Breaking Hot Stocks news story on Harley-Davidson »

Harley-Davidson sees cost…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

NFLX

Netflix

$277.99

2.59 (0.94%)

09:34
10/22/19
10/22
09:34
10/22/19
09:34
Recommendations
Netflix analyst commentary  »

Netflix to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 21

    Nov

ZYXI

Zynex

$10.89

0.41 (3.91%)

09:32
10/22/19
10/22
09:32
10/22/19
09:32
Periodicals
Zynex mentioned cautiously in a Seeking Alpha blog 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MDP

Meredith

$37.05

0.28 (0.76%)

09:31
10/22/19
10/22
09:31
10/22/19
09:31
Hot Stocks
Meredith sells Money brand to Ad Practioners; terms not disclosed »

Meredith Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

HRB

H&R Block

$23.73

0.45 (1.93%)

09:31
10/22/19
10/22
09:31
10/22/19
09:31
Hot Stocks
H&R Block names Jamil Khan as Chief Strategy & Development Officer »

H&R Block announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$37.14

0.555 (1.52%)

09:30
10/22/19
10/22
09:30
10/22/19
09:30
Hot Stocks
Harley-Davidson on track to build motorcycles in Thailand to ship to EU »

Harley-Davidson expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

STMP

Stamps.com

$76.12

0.55 (0.73%)

, UPS

UPS

$118.56

1.23 (1.05%)

09:30
10/22/19
10/22
09:30
10/22/19
09:30
Recommendations
Stamps.com, UPS analyst commentary  »

Stamps.com pact with UPS…

STMP

Stamps.com

$76.12

0.55 (0.73%)

UPS

UPS

$118.56

1.23 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 07

    Nov

CRAY

Cray

$0.00

(0.00%)

, HPE

HP Enterprise

$15.97

0.61 (3.97%)

09:29
10/22/19
10/22
09:29
10/22/19
09:29
Hot Stocks
Cray awarded GBP48M contract to for Shasta supercomputer »

Cray (CRAY), a Hewlett…

CRAY

Cray

$0.00

(0.00%)

HPE

HP Enterprise

$15.97

0.61 (3.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 09

    Dec

09:28
10/22/19
10/22
09:28
10/22/19
09:28
Conference/Events
House Financial Services Committee to hold a hearing »

The Subcommittee on…

CDNS

Cadence Design

$66.67

1.07 (1.63%)

09:28
10/22/19
10/22
09:28
10/22/19
09:28
Recommendations
Cadence Design analyst commentary  »

Cadence Design to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 19

    Nov

WYY

WidePoint

$0.34

-0.0015 (-0.44%)

09:28
10/22/19
10/22
09:28
10/22/19
09:28
Hot Stocks
WidePoint receives $14.7M in recent contract awards for TEM, MMS »

WidePoint Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEC

Alphatec

$5.48

0.11 (2.05%)

09:26
10/22/19
10/22
09:26
10/22/19
09:26
Hot Stocks
Alphatec announces commercial launch of titanium line of IdentiTi implants »

Alphatec Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

AVAV

AeroVironment

$57.93

0.07 (0.12%)

09:26
10/22/19
10/22
09:26
10/22/19
09:26
Hot Stocks
AeroVironment receives $5.25M Puma 3 AE contract for U.S. Border Patrol »

AeroVironment received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

IR

Ingersoll-Rand

$117.95

0.65 (0.55%)

09:25
10/22/19
10/22
09:25
10/22/19
09:25
Conference/Events
Senate Energy & Natural Resources Committee to hold a hearing »

The Committee holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

09:25
10/22/19
10/22
09:25
10/22/19
09:25
Conference/Events
UBS tech analyst/industry conference call has a time change »

TIME CHANGE: Technology…

W

Wayfair

$112.81

3.42 (3.13%)

09:24
10/22/19
10/22
09:24
10/22/19
09:24
Recommendations
Wayfair analyst commentary  »

Wayfair price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.